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Semi-varying coefficient multinomial logistic
regression for disease progression risk prediction
Yuan Ke,a Bo Fub,c∗† and Wenyang Zhangd
This paper proposes a risk prediction model using semi-varying coefficient multinomial logistic regression. We use
a penalized local likelihood method to do the model selection and estimate both functional and constant coefficients
in the selected model. The model can be used to improve predictive modelling when non-linear interactions between
predictors are present. We conduct a simulation study to assess our method’s performance and the results show
that the model selection procedure works well with small average numbers of wrong-selection or missing-selection.
We illustrate the use of our method by applying it to classify the patients with early rheumatoid arthritis at baseline
into different risk groups in future disease progression. We use a leave-one-out cross-validation method to assess
its correct prediction rate and propose a recalibration framework to evaluate how reliable are the predicted risks.
Copyright c⃝ 2010 JohnWiley & Sons, Ltd.
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1. Introduction
The motivation for this paper arose from a medical study, where the research interest is to classify the patients with early
inflammatory polyarthritis to three groups at different risk of progression to functional disability by using their baseline
information. The outcome of interest is a patient’s functional disability status at the end of a 5-year follow up, which is
a discrete variable having three levels (low risk, moderate risk, high risk) of disability. Such a risk prediction model is
important in medical application in order to identify a sub-group of patients at early stage of disease onset who are at
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higher risk to progress to a worse outcome so that more aggressive treatment strategies, such as use of biologic therapy,
could be matched to them [1, 2, 3].
Logistic regression models are widely used for developing predictive models where the outcome of interest is a
dichotomous or nominal-scaled variable. When the outcome variable can take more than two values, a multinomial
logistic regression is usually applied [4]. New multi-category classification methods in multinomial logistic regression
were recently discussed in Li et al. [5].
However usual logistic regression models assume that the effects of predictors on outcomes are constant. We relax
this assumption by incorporating a varying coefficient structure to allow the effects of the predictors to vary smoothly
with the change in a single continuous covariateU , such as baseline disease duration in our motivating example. Varying
coefficient models were introduced by Cleveland et al. [6] as a useful nonparametric tool to analyze complex dynamic data
[7, 8, 9, 10, 11, 12, 13, 14]. In particular, the use of such a nonparametric structure permits nonlinear interactions between
the predictors and a particular variable, which could be useful to improve the model fitting [7, 15, 16]. For example, in
Section 4 we will consider a relatively large number of candidate covariates at baseline for predicting future progression
to functional disability in early inflammatory polyarthritis patients. The set of candidate covariates may include patients’
demographic factors (e.g., age, gender), serological and genetic factors (e.g., rheumatic factor status, number of copies of
shared epitope), disease activity and severity measures (e.g., number of swollen or tender joints), social-economic factors
(e.g., index of multiple deprivation score), etc [3]. The number of potential predictors could be large if more biomarkers are
available at baseline. It is of interest to allow the effects of some baseline predictors to depend on the disease duration from
disease symptom onset to the baseline time when predictor variables were measured. By incorporating flexible interactions
between the effects of baseline predictors and disease duration in the prediction model, we account for influences due to
variations over time from disease onset to baseline between subjects. The research questions are then 1) which variables
among a large number of candidates should be selected in the predictive model; and 2) which variables have varying
effects among the selected predictors.
Variable selection is an essential part of statistical analysis to improve model predictability. Failing to select predictors
which are associated with an outcome will lead to bias. On the other hand, the prediction power may be reduced if we
include variables unrelated to the outcome. The coefficient estimates in a logistic regression could be biased if we include
too many unrelated covariates. Traditional methods, such as stepwise deletion and best-subset selection based on AIC
or BIC, are commonly used, but they tend to select an over-fitting model in a logistic regression, leading to inaccurate
scientific conclusion [17]. Also, traditional methods will be impractical if a large number of candidate predictors are
included. They are computationally intensive and might be unstable due to their inherited discreteness [18].
When the number of candidate covariates is large, the traditional statistical methods can easily fail due to the so called
“curse of dimensionality” [19]. The new generation of variable selection methods based on penalized functions, such
as ridge regression [20], the least absolute shrinkage and selection operator (LASSO) [21], smoothly clipped absolute
deviation (SCAD) [22], group LASSO [23], adaptive LASSO [24], Minimax Concave Penalty [25], as well as Bayesian
hierarchical models [26], have become particularly attractive in the analysis of high-dimensional data. These penalized
methods can do the model selection and the parameter estimation simultaneously through a constrained optimization. The
likelihood function and the constraints (usually expressed as penalties) together make a trade off between the goodness
of fit and the model complexity. Given an appropriate penalty function, the penalized methods can remove the unrelated
covariates and reduce the dimensionality.
The modern variable selection methods based on penalized functions have also been extended to nonparametric
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models such as varying coefficient models. For example, Wang and Xia [11] proposed a K-LASSO method based on
group penalization and quadratic approximation to handle the model selection for varying coefficient models. Lian [27]
considered the variable selection for high dimensional generalised varying coefficient models. Li et al.[28] proposed a
variable selection and structure identification method for generalised semi-varying coefficient models. Other recent related
work on variable selection includes Kong and Xia [29] for a single-index model, Tao and Xia [30] for an adaptive semi-
varying coefficient model, Kuk et al. [31] for predictive modelling based on logistic regression, Stefanski et al. [32] for
nonparametric classification methods.
In this paper, we consider variable selection for semi-varying coefficient multinomial logistic regression and introduce
a multi-category grouping method for risk prediction in chronic disease progression. An attractive feature of our method
is that it not only selects predictors but also select their coefficient types (constant or functional). It also allows the number
of potential covariates to increase with sample size and is able to handle the case where the number of potential variables
is large. This would be particularly useful in practice as we may include all available potential predictors to improve
prediction accuracy. Our method contains two steps:
1. Model selection and parameter estimation. We start with a full multinomial logistic regression model including
all candidate covariates and apply a penalized likelihood approach to select predictors and the types of their coefficients
(constant or functional). We then estimate both constant and functional coefficients for the selected model.
2. Prediction. For each subject, we calculate the conditional probabilities that this subject belongs to different risk
groups based on the selected model and its estimated coefficients. A subject is predictable if the maximum of the estimated
group-membership probabilities exceeds a given threshold and is then classified to the corresponding risk group with the
largest group-membership probability.
In the above procedures, Step 2 just involves some trivial calculations and the key step for our modelling is the model
selection part.
The rest of this paper is arranged as follows. In Section 2, we introduce the scientific motivation of this paper. In Section
3, we discuss the proposed risk prediction model in detail, which is based on the ideas of kernel smoothing, penalized
likelihood, local linear approximation and penalization on deviations. The selection of tuning parameters is presented in
Section 3.3. Section 4 focuses on an application to inflammatory polyarthritis data. In the end, Section 5 gives a brief
discussion.
2. Motivating data example
2.1. Scientific motivation
Our work was motivated by an analysis of a medical dataset from a primary care-based prospective cohort of patients
with recent onset inflammatory polyarthritis [33]. Rheumatoid arthritis (RA) is the most common inflammatory disease
of the joints, which is associated with progressive joint destruction resulting in severe disability. However, it is difficult
to identify RA at an early stage of disease onset because no tests or diagnostic criteria are available to define early RA
[34]. A lab test that often helps with diagnosis of RA at a follow up stage is anti-cyclic citrullinated peptide antibody test.
Early arthritis may be progressed into established RA or another definite arthritis disease or may remain undifferentiated.
To better manage the outcome in arthritis, it has been suggested by clinical researchers to first recognize inflammatory
arthritis and then estimate the risk of developing persistent and erosive irreversible arthritis such as RA in order to propose
an optimal treatment option [35].
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RA is a very heterogeneous disease in term of disease progression outcome. Some RA patients do not develop any severe
outcome, such as erosion, even after a long time, but the majority will have bone erosion and cartilage breakdown resulting
in joint destruction and functional disability. For the management of early inflammatory polyarthritis, the European League
against Rheumatism recommends that patients at risk of developing persistent and/or erosive arthritis should be started
with disease-modifying anti-rheumatic drugs (DMARDs) as early as possible, even if they do not yet fulfil established
classification criteria for RA [36]. Furthermore, the revolutionary introduction of biologic agents, such as anti-tumour
necrosis factor (TNF), in the past decade offers patients a new and very effective treatment option alternative to the
traditional DMARDs. Early treatment with biologic agents has been shown by published studies to improve clinical
outcomes, patients’ functional status and health-related quality of life [37]. However, biologic agents have potential to
leave the patients more vulnerable to severe adverse events such as infection or malignancy because TNF is involved in
many aspects of host immunity [38]. Also the drug costs of treatment with biologic agents are much higher compared to
DMARDs.
In order to achieve the goal of personalised treatment and optimal early use of biologic agents in the management of
RA, it is necessary to identify a sub group of patients at baseline who are at higher risk to progress into a worse functional
status in future or have better response to biologics treatment so that specific treatment strategies are matched to individual
patients. In this paper, our scientific interest focuses on a prediction model to classify the patients into groups with different
risk of progression to severe outcome rather than different responses to treatment. An ideal therapeutic strategy should
then be based on such an appropriate prediction of the disease progression risk [36]. The aim of this study is to improve
the predictive modelling by identifying significant prognostic factors (or predictors) associated with disease progression
together with their significant interactions.
2.2. HAQ progression data
The data sample we study comprises 290 patients, who were recruited to the arthritis register cohort between 1990-
1994 and have disease duration from symptom onset to registration less than 3 years. The disease outcome of interest is
functional disability status, which is an important clinical measure in RA as it has been shown to be predictive of crucial
RA-related outcomes, such as mortality. This measure was assessed using the modified British version of the Health
Assessment Questionnaire (HAQ) score. The questionnaire comprises 20 questions in 8 categories. Each question is given
a score of 0 (no difficulty), 1 (some difficulty), 2 (much difficulty or need of assistance), or 3 (unable to perform). The
score for each category is determined by the highest score in that category, and the sum of scores is then divided by the
number of categories, yielding a total HAQ score ranging from 0 (best) to 3 (worst). All patients in our study sample have
mild disease outcome at registration (baseline) with baseline HAQ scores between 0 and 1 and were followed for at least
5 years. The response variable Y is the functional disability status at the end of a 5-year follow up since registration. Y = 1
if the functional disability status at the end of follow up is at low risk (HAQ score between 0 and 1); 2 if the functional
disability status is at moderate risk (HAQ score between 1 and 2); and 3 if the functional disability status is at high risk
(HAQ score between 2 and 3). Such a classification into 3 groups based on HAQ score was suggested by Wolfe et al
[39] and it provides important and clinically useful current and predictive information regarding RA status, utilization of
services, and mortality [39].
In the predictive model, the candidate predictors include age at registration, gender, number of swollen joints out
of 51 joints, number of tender joints of 51 joints, rheumatic factor (1=positive or 0= negative), smoking status (three
categories: non-smoker, current smoker or ex-smoker), socio-economic status defined as a area-level category variable
4 www.sim.org Copyright c⃝ 2010 John Wiley & Sons, Ltd. Statist. Med. 2010, 00 1–15
Prepared using simauth.cls
Y. KE, B. FU ANDW. ZHANG
Statistics
in Medicine
based on the nationally-determined quartiles of the index of multiple deprivation score used in the UK (four categories:
least deprived group, two middle deprived groups, most deprived group) [3], number of copies of the shared epitope
which is an established genetic biomarker in RA, fulfilment of the American College of Rheumatology 1987 classification
criteria for rheumatoid arthritis (RA: 1= yes or 0 = no), season of birth (four categories: spring, summer, autumn or winter),
DMARDs treatment duration (in days), baseline HAQ score and their functional interactions with disease duration from
symptom onset (in months).
The first scientific question is which of the above baseline covariates are good predictors of the disease progression
outcome Y at the end of a 5-year follow up. Second, as patients have various disease duration at registration (baseline),
it is of interest to know whether the effects of any of selected predictors on the outcome Y have interactions with the
change of disease duration from disease symptom onset to the baseline time when these covariates were measured. Our
assumption is that such interactions may not be fully modelled by adding linear interaction terms and this motivates us to
consider a semi-varying coefficient logistic regression to allow non-linear interactions.
3. Methodology
3.1. A semi-varying coefficient multinomial logistic regression model
Suppose we have a sample (yi, Ui, xi1, · · · , xidn), i = 1, · · · , n, from (y, U, x1, · · · , xdn). y is a categorical disease
outcome variable of S levels of risk; U is a given continuous variable, such as baseline disease duration in the motivating
example in Section 2; and x j, j = 1, · · · , dn, are either continuous or discrete covariates whose effects may be constant or
vary with the level ofU . Throughout this paper, without loss of generality, we assume y ∈ {1, · · · , S}, and take level S as
reference.
Assume the conditional probability that the ith subject belongs to the risk category s is psi = P(yi = s |Ui, xi1, . . . ,xidn),
where i= 1, . . . ,n and s= 1, . . . ,S. To incorporate nonlinear interactions between x j andU into the modelling, we specify
all psis through a semi-varying coefficient multinomial logistic regression, i.e.
psi =
exp(∑dnj=1 xi jas j(Ui))
1+∑S−1k=1 exp(∑dnj=1 xi jak j(Ui))
, s= 1, . . . , S−1,
pSi =
1
1+∑S−1k=1 exp(∑dnj=1 xi jak j(Ui))
, (3.1)
where ak j(·) are unknown coefficients that are either constant or functional and ∑Ss=1 psi = 1. A constant coefficient ak j(·)
means that there is no interaction between xi j andUi. It follows that the logit of category s versus the reference category S
is ln
(
psi
pSi
)
= ∑dnj=1 xi jas j(Ui).
3.2. Model selection, estimation and prediction
Throughout this section, for any function f (·), we use f˙ (·) to denote its first derivative and f¨ (·) to denote its second
derivative.
3.2.1. Model selection We now describe how to select the predictor variables in (3.1) and identify which coefficients are
constant and which are functional. This is basically a model selection problem. Based on the penalized likelihood idea,
the model selection problem is transformed to an estimation problem of the unknown coefficients, ak j(·)s, in (3.1). In the
following, we are going to apply the penalized local maximum likelihood estimation to estimate ak j(·)s in (3.1).
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It is easy to see the conditional log likelihood function of ak j(·)s, given all potential predictors, in (3.1) is
n
∑
i=1
{
S−1
∑
s=1
I(yi = s)
dn
∑
j=1
xi jas j(Ui)− log
(
1+
S−1
∑
l=1
exp
{
dn
∑
j=1
xi jal j(Ui)
})}
(3.2)
For each given k, k = 1, . . .,n, within a small neighbourhood ofUk, a Taylor’s expansion gives
as j(Ui)≈ as j(Uk)+ a˙s j(Uk)(Ui−Uk),
where i= 1, . . . ,n, and j = 1, . . .,dn. This leads to the following local conditional log-likelihood function
ℓk(ak, dk) =
n
∑
i=1
Kh(Ui−Uk)
{
S−1
∑
s=1
I(yi = s)
dn
∑
j=1
xi j
{
αs jk+βs jk(Ui−Uk)
}
−
log
(
1+
S−1
∑
l=1
exp
[
dn
∑
j=1
xi j
{
αl jk+βl jk(Ui−Uk)
}])}
where αs jk corresponds to as j(Uk) and βs jk corresponds to a˙s j(Uk), K(·) is a kernel function, h is a bandwidth,
Kh(·) = 1hK(·/h),
ak = (α11k, . . . , α1dnk, . . . , α(S−1)1k, . . . , α(S−1)dnk)T,
dk = (β11k, . . . , β1dnk, . . . , β(S−1)1k, . . . , β(S−1)dnk)T.
Adding all ℓk(ak, dk), k = 1, · · · , n, together, we have
Ln(A , B) =
n
∑
k=1
ℓk(ak, dk), (3.3)
where
A = (aT1 , . . . , aTn )T, B = (dT1 , . . . , dTn )T.
Denote
∥u∥= (uTu)1/2, αs j = (αs j1, · · · , αs jn)T,
Ds j =
{
n
∑
k=1
(αs jk− α¯s j)2
}1/2
, and α¯s j = 1n
n
∑
k=1
αs jk.
This leads to the following penalized local conditional log-likelihood function for the model selection
Qn(A , B) =Ln(A , B)−
S−1
∑
s=1
dn
∑
j=1
pλ1s j(Ds j)−
S−1
∑
s=1
dn
∑
j=1
pλ2s j(
∥∥αs j∥∥), (3.4)
where pλ (·) is the SCAD penalty function with tuning parameter λ , which is defined through its derivative
p˙λ (z) = λ
[I(z≤ λ )+ (a0λ − z)+
(a0−1)λ I(z> λ )
]
,
where a0 = 3.7 as suggested in Fan and Li [22].
To directly maximise Qn(A , B) can be very challenging. We are going to find a quadratic function and use its
maximiser to approximate the maximiser ofQn(A , B), thereby simplifying the maximisation.
Let (A˜n, B˜n) be the maximiser of Ln(A , B), α˜s jk the component of A˜n which corresponds to αs jk. α˜s j is αs j with
αs jk replaced by α˜s jk. D˜s j is Ds j with αs jk replaced by α˜s jk.
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Noticing L˙n(A˜n, B˜n) = 0, by the Taylor’s expansion, we have
Ln(A , B)≈Ln(A˜n, B˜n)
+
1
2
((
A − A˜n
)T
, h
(
B− B˜n
)T)
L¨n(A˜n, B˜n)
⎛⎝ A − A˜n
h
(
B− B˜n
) ⎞⎠ ,
and for s= 1, · · · , S−1, j = 1, · · · , dn,
pλ1s j(Ds j)≈ pλ1s j(D˜s j)− p˙λ1s j(D˜s j)D˜s j+ p˙λ1s j(D˜s j)Ds j,
pλ2s j(
∥∥αs j∥∥)≈ pλ2s j(∥∥α˜s j∥∥)− p˙λ2s j(∥∥α˜s j∥∥)∥∥α˜s j∥∥+ p˙λ2s j(∥∥α˜s j∥∥)∥∥αs j∥∥ .
Let
Ln∗(A , B) =
1
2
(
(A − A˜n)T, h(B− B˜n)T
)
L¨n(A˜n, B˜n)
(
A − A˜n
h(B− B˜n)
)
,
and
P1n,s j(Ds j) = p˙λ1s j(D˜s j)Ds j, P2n,s j(
∥∥α j∥∥) = p˙λ2s j(∥∥α˜s j∥∥)∥∥αs j∥∥
We define
Qn∗(A , B) =Ln∗(A , B)−
S−1
∑
s=1
dn
∑
j=1
P1n,s j(Ds j)−
S−1
∑
s=1
dn
∑
j=1
P2n,s j(
∥∥α s j∥∥),
and use the maximiser of Qn∗(A , B) to approximate the maximiser of Qn(A , B) and estimate the corresponding
unknown parameters.
By the local linear approximation, the maximisation of Qn∗(A , B) can be considered as an iterative re-weighted
LASSO problem. Hence given an initial estimator,Qn∗(A , B) can be maximised through an iterative algorithm similar
as in Li et al.[28]. The computational cost is moderate.
Let (αˆs j, βˆ s j), s = 1, · · · , S− 1, j = 1, · · · , dn, be the maximiser of Qn∗(A , B). For the penalty functions which
enjoy sparsity property, such as SCAD or L1 penalty, our feature selection and model specification procedure works as
follows: if ∥αˆs j∥ = 0, then the corresponding variable x j is not significant and should be removed from modelling the
conditional probability P(y = s|U,x1, · · · ,xdn) of y falling in level s. Let Dˆs j be Ds j with αs j replaced by αˆs j. If Dˆs j = 0,
the coefficient of x j is constant when modelling P(y= s|U,x1, · · · ,xdn).
3.2.2. Estimation After the model is selected, we apply the standard local maximum likelihood estimation to estimate the
coefficients based on the selected model. The details are as follows.
Suppose the set of the subscripts of the variables with functional coefficients, in the selected model for P(y =
s|U, x1, · · · , xdn), is Ωs, with constant coefficients is ∆s. For any given u, by simple calculation, we have the following
local conditional log likelihood function
n
∑
i=1
Kh(Ui−u)
{
S−1
∑
s=1
I(yi = s)
[
∑
j∈Ωs
xi j
{
αs j+βs j(Ui−u)
}
+ ∑
l∈∆s
xilαsl
]
− log
(
1+
S−1
∑
k=1
exp
[
∑
j∈Ωk
xi j
{
αk j+βk j(Ui−u)
}
+ ∑
l∈∆k
xilαkl
])}
.
Let (αˆs j(u), βˆs j(u)), j ∈Ωs∪∆s, s= 1, · · · , S−1, be the maximiser of this local conditional log likelihood function at u.
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For any j ∈ Ωs, the estimator aˆs j(u) of the functional coefficient as j(u) is taken to be αˆs j(u). For any l ∈ ∆s, the
coefficient asl(·) is constant which is denoted byCsl , and can be estimated by
Cˆsl =
1
n
n
∑
i=1
αˆsl(Ui).
Remark. The Taylor’s expansion based local maximum likelihood estimation used in this paper is an important
nonparametric estimation method. Theoretically speaking, the estimation error due to the linear approximation is of order
Op(h2), see Li et al. [28]. Practically, this would be very small as long as the sample size is reasonable. The limitation of
the local maximum likelihood estimation is that all functions, which are approximated by linear functions, are required to
have continuous second derivative.
3.2.3. Prediction Once the model is specified and the coefficients in the selected model are estimated, the risk prediction
becomes straightforward: for a new subject, if the observation of the predictor is (Ul, xl1, . . . , xldn), the conditional
probability of this subject falling in risk level s, s ∈ {1, · · · , S−1}, given (Ul , xl1, . . . , xldn) can be estimated by
pˆsl =
exp
(
∑
j∈Ωs
xl jaˆs j(Ul)+ ∑
j∈∆s
xl jCˆs j
)
1+
S−1
∑
k=1
exp
(
∑
j∈Ωk
xl jaˆk j(Ul)+ ∑
j∈∆k
xl jCˆk j
) . (3.5)
Let
pˆSl = 1−
S−1
∑
s=1
psl
and sˆ maximise pˆsl with respect to s on {1, · · · , S}. If pˆsˆl is greater than a given threshold, this new subject is predictable
under this threshold. Then we classify it into risk level sˆ.
3.3. Selection of tuning parameters
The tuning parameters λ1s j and λ2s j, j = 1, · · · , dn, s = 1, · · · ,S− 1, involved in the proposed estimation and model
selection procedure play a very important role. In this subsection, we will address how to choose these tuning parameters.
If we use a proper penalty function, such as SCAD, it would be reasonable to set all λ1s j’s to have the same value and
all λ2s j’s to have the same value. This is because the need of different tuning parameters for different coefficients would
be met by the use of a proper penalty function. From now on, we use λ1 and λ2 to denote the common value of λ1s j’s and
λ2s j’s respectively, and select λ1 and λ2 by the generalized information criterion (GIC) proposed by Fan and Tang [40].
As the model concerned involves both unknown constant parameters and unknown functional parameters, to use GIC,
we first need to figure out how many unknown constant parameters an unknown functional parameter amounts to. Cheng
et al.[10] suggested that an unknown functional parameter would amount to 1.028571h−1 unknown constant parameters
when Epanechnikov kernel K(t) = 0.75(1− t2)+ was used. Taking their suggestion, we construct the GIC for model (3.3)
as
GIC(λ1, λ2) =−2
n
∑
k=1
ℓk(aˆk, dˆk),
+2ln{ln(n)}ln{1.028571(S−1)dnh−1}(k1+1.028571k2h−1),
where aˆk and dˆk are the estimators of ak and dk obtained based on the tuning parameters λ1 and λ2. k1 is the number of
significant covariates with constant coefficients obtained based on the tuning parameters λ1 and λ2, and k2 is the number
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of significant covariates with functional coefficients obtained based on the tuning parameters λ1 and λ2. The minimiser of
GIC(λ1, λ2) is the selected λ1 and λ2.
4. Application to the HAQ progression data
4.1. Data analysis
We fitted model (3.1) to the HAQ data and considered the disease duration variable as the covariate U . One of the
advantages of the proposed semi-varying coefficient multinomial logistic regression model is to allow us to incorporate
potentially varying effects of baseline covariates with the change of U . It is more flexible and more general than the
one including linear interaction terms between baseline covariates and U . Without loss of generality, we re-scaled the
covariate U to [0,1]. The response category Y = 1 was chosen as the reference and the other two categories were
compared against the reference category. We considered 18 candidate covariates including all numerical or dummy
variables listed in Section 2.2. We used the proposed risk prediction methods discussed in Section 3.2 to do the model
selection, estimation and prediction. The kernel function was chosen as the Epanechnikov kernel, and the bandwidth was
chosen as h= 0.6[(S−1)dn/n]0.2. The tuning parameters λ1 and λ2 were selected by GIC [28, 40] as discussed in Section
3.3.
The selected predictors together with their estimated coefficients (constant or functional) are presented in Table 1 and
Table 2. For those functional coefficients, we report their estimates and associated standard errors at givenU values with
the disease duration being 1, 3, 6, 12 or 24 months. The standard errors of the coefficient estimates were calculated by
a bootstrap method. Among the list of candidate covariates, twelve were selected to be significantly associated with the
multinomial logit of the response group Y = 2 (moderate risk) relative to the reference group Y = 1 (low risk). Three of
them (RA, female, current smoker) have constant coefficients and are associated with increased probability of being in
the higher risk groups. The others (baseline HAQ score, number of swollen joints, number of tender joints, DMARDs
treatment duration, age at onset, copies of genetic biomarker, previous smoker, upper middle deprived group, and most
deprived group) have functional coefficients, which means that their effects are varying with the change of baseline disease
duration. For the multinomial logit of the response group Y = 3 (high risk) relative to the low risk group, eight covariates
together with a functional intercept were selected in the model. Two of them (baseline HAQ, rheumatic factor) have
constant coefficients and six (number of swollen joints, number of tender joints, DMARDs treatment duration, age at onset,
copies of genetic biomarker, upper middle deprived group) have functional coefficients. All of the selected covariates in
Table 1 and Table 2 are indeed well acknowledged predictors in HAQ progression (see for example, Combe et al. [41]).
Fewer predictors were identified in Table 2 due to the smaller sample size of 23 in Group Y = 3 comparing to 74 in Group
Y = 2. It is interesting but not surprising to see that the effects of smoking status and genetic biomarker with short baseline
disease duration (1 or 3 months) contribute more toward higher risk, while the effects of clinical variables (i.e., baseline
HAQ sore, number of tender joints) with long baseline disease duration (24 months) contribute more toward higher risk.
The scientific aim of this study is to classify the patients at baseline into different risk groups to predict their outcomes
at the end of follow up. Hence we assess the performance of our methods by comparing the correct prediction rate
with other existing methods. The calculation of the correct prediction rate is based on a leave-one-out cross-validation
approach. For each subject, we used the rest of the data (289 subjects) to select covariates and obtain their coefficient
estimates. We then calculated the estimated conditional probability of belonging to low, moderate or high risk levels for
this subject. If one of the estimated conditional group-membership probabilities is higher than a threshold, say 80% or
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70%, we classify this subject into the corresponding group and compare the prediction result with the true value of Y . By
repeating this procedure to all subjects, we calculated correct prediction rates for those subjects who have a maximum of
the estimated group-membership probabilities greater than the threshold. The results are shown in Table 3, where the ”Total
prediction No.” means the numbers of subjects with a maximum group-membership probability greater than the threshold
(80% or 70%) and the ”Correct prediction No.” means the numbers of subjects correctly grouped. The correct prediction
rates, which are ratios between the correct prediction numbers and the total prediction numbers, are compared between
our method and alternative competitors. The alternative competitors include “SCAD constant coefficient model”, “Full
varying coefficient model” and “Full constant coefficient model”. The “SCAD constant coefficient model” is selected by a
SCAD penalized multinomial logistic regression with constant coefficients. The “Full varying coefficient model” means a
varying coefficient multinomial logistic regression including all covariates with functional coefficients. The “Full constant
coefficient model” means a multinomial logistic regression including all covariates with constant coefficients. We see
that our selected model always gives better correct prediction rates comparing to all the competitors by reducing false
prediction numbers significantly. Its correct prediction rate could reach as high as 85.2% when the threshold probability
is 0.8. The SCAD constant coefficient model performs better than the two full models. The above results justified
the motivation of the proposed method as both varying coefficient assumption and model selection are crucial to the
improvement of prediction performance. The total computation time for this subsection is about 2 hours.
4.2. Reliability of prediction
To evaluate the reliability of the proposed risk prediction model, we consider a recalibration framework in this subsection.
Recalibration methods that involve the estimation of calibration intercept and calibration slope are well-recognized
approaches to assess the reliability of prediction models [42, 43]. The logistic recalibration framework for the risk
prediction models with binary outcomes has been proposed in existing literature [44, 45]. Recently Van Hoorde et al. [46]
extended this recalibration tool for nominal polytomous outcomes. In this paper, we extend the recalibration framework
proposed by Van Hoorde et al. [46] to propose new calibration tools, including calibration intercept and calibration slope,
to assess the reliability of the proposed prediction model based on semi-varying coefficient multinomial logistic regression.
The calibration intercept, calibration slope and their confidence intervals were calculated as follows.
We divided the HAQ data sample into two datasets: a prediction dataset including 200 subjects and a validation dataset
including 90 subjects. First we used the prediction data to do the model selection. Based on the selected model and the
estimated coefficients, we used the validation data to estimate the intercept and the slope of a recalibration multinomial
regression model as follows.
DenoteΩs and ∆s the set of the subscripts of the variables with functional and constant coefficients in the selected model
for category s respectively, s= 2,3. We fitted the following recalibration model to the validation data for l = 1, · · · ,90:⎧⎪⎨⎪⎩
log
[
P(Yl=2)
P(Yl=1)
]
= γ20+ γ21
(
∑
j∈Ω2
xl jaˆ2 j(Ul)+ ∑
j∈∆2
xl jCˆ2 j
)
, for Yl = 2,
log
[
P(Yl=3)
P(Yl=1)
]
= γ30+ γ31
(
∑
j∈Ω3
xl jaˆ3 j(Ul)+ ∑
j∈∆3
xl jCˆ3 j
)
, for Yl = 3,
(4.1)
where aˆ2 j(.), aˆ3 j(.), Cˆ2 j and Cˆ3 j were obtained by applying the method proposed in Section 3.2.2 to the prediction data; γs0
and γs1 are the intercept and the slope for the sth category, s= 2,3. We estimated the calibration slopes γˆs1 and calculated
their 95% Wald-type confidence intervals. Similarly, we calculated the calibration intercepts and their 95% Wald-type
confidence intervals except that all γˆs0s were obtained by fixing the corresponding slopes γs1 equal to 1 [46].
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The calibration slope and the calibration intercept are important aspects of calibration, assessing the amount of model
overfitting and difference between observed outcome versus predicted outcome respectively [42, 43]. When the risks
are perfectly calibrated, the calibration slope is 1 and the calibration intercept is 0 [46]. In addition, their confidence
intervals should be reasonably small. Comparisons of the estimated calibration slopes and calibration intercepts between
our method, the “SCAD constant coefficient model” and the “Full varying coefficient model” are presented in Table 4. It
shows clearly that the model selected by our method is more reliable because its calibration intercept is more close to 0
(observed outcomes agree more with predicted risks) and its calibration slope is more close to 1. The calibration slopes
for the “SCAD constant coefficient model” (i.e., 0.83 and 0.86) and for the “Full varying coefficient model” (i.e., 0.76 and
0.78) suggest more overfitting in both models. The total computation time for this subsection is about 1 hour.
4.3. Simulation study
To examine the performance of the proposed method in Section 3, we conduct a simulation study to answer two questions:
1) whether the proposed model selection procedure works well to select correct predictors and the types of their coefficients
(constant or functional); 2) whether the developed prediction model works well to classify subjects into different risk
groups using baseline information.
We generated a simulated dataset which mimics the real HAQ progression data. The covariates x j’s were generated
independently as follows. If the jth covariate in the HAQ progression data is continuous, x j was generated from a normal
distribution with its mean and variance being equal to the sample mean and the sample variance of the jth covariate. If the
jth covariate is discrete, then x j was generated from a discrete distribution taking the same values with probabilities being
equal to the sample probabilities estimated from the HAQ progression data. The covariateU was generated independently
from Uni f orm [0, 1]. The response variable Y ∈ {1, 2, 3} was generated from the following multinomial logistic
regression model: ⎧⎪⎨⎪⎩
log
[
P(Y=2)
P(Y=1)
]
= ∑
j∈Ω2
x ja2 j(U)+ ∑
j∈∆2
x jC2 j, for Y = 2,
log
[
P(Y=3)
P(Y=1)
]
= ∑
k∈Ω3
xka3 j(U)+ ∑
k∈∆3
xkC3 j, for Y = 3,
(4.2)
whereΩ2,Ω3, ∆2 and ∆3 refer to the model selected in Section 4.1; a2 j(·), a3 j(·),C2 j andC3 j are the same as the estimated
coefficients in Section 4.1. In Section 4.3, model (4.2) is considered as the true model and a2 j(·), a3 j(·), C2 j and C3 j are
considered as the true coefficients.
We considered different scenarios with sample sizes n being equal to 200, 300 or 400. For each scenario, we generated
a training dataset of sample size n from (4.2). The simulation was conducted in the following steps:
(i) Select the model and estimate a2 j(·), a3 j(·),C2 j and C3 j using the training data;
(ii) Generate a separate testing dataset such that there are 100 subjects in each response category; apply the estimated
model obtained in Step (i) to predict the response Y for each subject in this testing dataset;
(iii) Generate a second testing dataset such that there is one response category into which subjects are classified with
conditional probabilities of 90%-100%, 80%-90% and 70%-80% respectively; keep simulating until each response
category has a sample size of 100; apply the estimated model obtained in Step (i) to predict the response Y for each
subject in the second testing dataset.
By repeating the above procedure for 200 realizations, we assess the model selection performance by reporting the
average numbers of correct-selection, wrong-selection and missing-selection for the logit of Y = 2 vs Y = 1 and the logit
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of Y = 3 vs Y = 1 respectively. The results are presented in Table 5, where “Correct-selection” means that the selected
covariates are true predictors and the procedure correctly selects their coefficient types (constant or functional); “Wrong-
selection” means that some selected covariates are false predictors or the procedure wrongly selects their coefficient types;
“Missing-selection” means that some true predictors are not selected in the procedure. It is seen that our proposed method
performs well in the model selection with small average numbers of wrong-selection and missing-selection. For example,
when selecting 13 (or 10) true predictors for the logit of Y = 2 (or Y = 3) vs Y = 1 among 21 candidate covariates, there
is about one covariate wrongly selected on average for n = 300, mainly due to wrong selection for its coefficient type. It
is less likely to miss a true predictor with an average number of missing-selection being 0.23 (or 0.20) for n= 300. When
the sample size is reduced to 200, the average numbers of wrong-selection and missing-selection slightly increase to 2 and
1 respectively.
In addition, we assess the out-of-sample performance of the estimated prediction model by applying it to separate
testing datasets. The average proportions of correct prediction in each category in Step (ii) and the average proportions of
subjects being classified into a correct category in Step (iii) are reported in the Panels (ii) and (iii) of Table 5 respectively.
In order to make a comparison, we report the simulation results from the “Oracle model”, which means that we know
the true model and the true coefficients, and a number of competitor methods available to be implemented, including the
“SCAD constant coefficient model” and the “Full constant coefficient model”, as explained in Section 4.1. We see that
the prediction performance of the estimated model is obviously better than those the two competitor methods and is close
to that of the “Oracle model” when n = 400. The computation of the simulation was performed using a small number of
computer clusters and the execution time is about 8 hours.
5. Discussion
In the management of chronic diseases, it is of interest to identify a sub-group of subjects at baseline who are at high
risk in future progression to a severe disease outcome and hence specific therapeutic strategies could be matched.
Many prognostic markers (predictors) are often taken into account in risk prediction modelling and the interactions
between predictor variables can be complicated. In this paper, we presented a semi-varying coefficient regression model
for improving the prediction modelling and conducted the model selection by a penalised likelihood approach. Based
on the ideas of penalization on deviation, kernel smoothing and quadratic function approximation, our method selects
significant predictors, determines whether each selected predictor has a constant or functional coefficient and estimates
their coefficients simultaneously. Another attractive feature of the proposed method is that it allows the number of
potential covariates to increase with the sample size. With rapid development of laboratory medicine, more potential
prognostic markers, including clinical and demographic features, environmental factors, serological factors, genetic
factors, epigenetic factors and their interactions, are considered as candidates predicting future disease outcome or
response to treatment in stratified medicine and the number of potential predictors could be very large. This paper focuses
on nonparametric risk prediction modelling and future work would be focussing on treatment-specific consideration in
stratified medicine and methods to predict response to treatment.
We consider the multinomial logistic regression as it is widely used in medical research for categorical outcomes. It
would be a topic of future work to extend the proposed method to an ordinal logistic regression context for the ordinal
outcome HAQ. For example, one could extend the current method by penalizing the likelihood of a proportional odds
logistic regression [47] for ordinal outcomes in a similar way. However a different algorithm may be required to handle
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the optimization of its penalized likelihood with constrained parameterization.
Our model allows non-linear interactions which include the usual type of interactions, such as product of x and U , as
special cases. For example, if the function a(U) in model (3.1) is linear, such as a(U)x = aUx, the model is specialized
to one with an usual type of linear interaction. From a modelling point of view, one can also entertain other potential
interactions between other covariates by including extra non-linear interaction terms (or other transformation) of the
covariates concerned in the model.
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Table 1. HAQ progression data: selected covariates for the logit of Y = 2 (moderate risk) vs Y = 1 (low risk) and their
coefficient estimates (standard errors) that are either constant or varying at selected disease durations.
Variable Type 1 month 3 months 6 months 12 months 24 months
RA constant 0.091 - - - - -
(yes or no) (0.051)
Female constant 0.144 - - - - -
(yes or no) (0.010)
Current smoker constant 0.093 - - - - -
(yes or no) (0.002)
Baseline HAQ score functional - 0.147 0.084 0.044 0.089 0.576
- (0.041) (0.019) (0.017) (0.023) (0.153)
Number of swollen joints functional - -0.011 -0.005 0.001 0.001 -0.028
- (0.004) (0.002) (0.0003) (0.0004) (0.007)
Number of tender joints functional - -0.007 -0.004 -0.0004 0.007 0.013
- (0.003) (0.001) (0.0001) (0.002) (0.005)
Treatment duration functional - -0.0002 -0.0001 0.0001 0.0002 0.0002
(days) - (0.0001) (0.0001) (0.0001) (0.0001) (0.0001)
Age at onset functional - -0.002 -0.001 -0.0004 0.000 -0.0002
- (0.0005) (0.0002) (0.0001) (0.0001) (0.0001)
Copies of genetic biomarker functional - 0.078 0.054 0.038 0.006 -0.104
- (0.028) (0.021) (0.015) (0.002) (0.033)
Previous smoker functional - 0.107 0.080 0.030 -0.032 -0.173
(yes or no) - (0.027) (0.019) (0.009) (0.007) (0.057)
Upper middle deprived group functional - 0.291 0.241 0.194 0.083 -0.184
(yes or no) - (0.086) (0.089) (0.046) (0.032) (0.053)
Most deprived group functional - 0.309 0.290 0.264 0.174 -0.176
(yes or no) - (0.101) (0.093) (0.088) (0.067) (0.068)
RA: fulfilment of the ACR 1987 classification criteria for rheumatoid arthritis; HAQ: Health Assessment
Questionnaire.
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Table 2. HAQ progression data: selected covariates for the logit ofY = 3 (high risk) vsY = 1 (low risk) and their coefficient
estimates (standard errors) that are either constant or varying at selected disease durations.
Variable Type 1 month 3 months 6 months 12 months 24 months
Baseline HAQ score constant 0.052 - - - - -
(0.0004)
Rheumatic factor constant 0.077 - - - - -
(positive or negative) (0.0008)
Intercept functional - -0.159 -0.149 -0.138 -0.098 0.025
- (0.043) (0.039) (0.052) (0.034) (0.007)
Number of swollen joints functional - 0.005 0.004 0.003 0.004 0.010
- (0.002) (0.001) (0.001) (0.001) (0.003)
Number of tender joints functional - -0.006 -0.004 -0.001 0.002 0.015
- (0.002) (0.001) (0.0003) (0.001) (0.007)
Treatment duration functional - 0.001 0.0004 0.0001 -0.0002 -0.0001
(days) - (0.0002) (0.0002) (0.0001) (0.0002) (0.0001)
Age at onset functional - 0.003 0.002 0.002 0.001 -0.001
- (0.001) (0.001) (0.0004) (0.0002) (0.0003)
Copies of genetic biomarker functional - 0.057 0.053 0.038 0.003 -0.054
- (0.018) (0.016) (0.015) (0.001) (0.021)
Upper middle deprived group functional - -0.095 -0.045 0.020 0.117 0.165
(yes or no) - (0.019) (0.016) (0.008) (0.044) (0.038)
HAQ: Health Assessment Questionnaire.
Table 3. HAQ progression data: comparison of the total prediction numbers, the correct prediction numbers and the correct
prediction rates among models.
Estimated conditional probability ≥ 80%
Model Total prediction No. Correct prediction No. Correct prediction rate
Our method 61 52 85.2%
SCAD constant coefficient model 72 51 70.8%
Full varying coefficient model 77 51 66.2%
Full constant coefficient model 81 50 61.7%
Estimated conditional probability ≥ 70%
Model Total prediction No. Correct prediction No. Correct prediction rate
Our method 120 93 77.5%
SCAD constant coefficient model 130 89 68.5%
Full varying coefficient model 138 88 63.7%
Full constant coefficient model 143 90 62.9%
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Table 4. HAQ progression data: estimated calibration intercepts and calibration slopes together with their 95% Wald-type
confidence intervals (in the brackets); the category Y = 1 is the reference.
Calibration intercept Calibration slope
Our method
Y = 2 -0.16 [-0.22; -0.06] 1.06 [0.93; 1.23]
Y = 3 0.23 [0.07; 0.38] 1.08 [0.88; 1.32]
SCAD constant coefficient model
Y = 2 -0.55 [-0.86; -0.22] 0.83 [0.70; 1.09]
Y = 3 0.44 [0.15; 0.81] 0.86 [0.72; 1.13]
Full varying coefficient model
Y = 2 -0.65 [-0.84; -0.34] 0.76 [0.47; 1.07]
Y = 3 1.04 [0.66; 1.32] 0.78 [0.53; 1.04]
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Table 5. Simulation study: comparison of the performances of our method, the SCAD constant coefficient model and the
full constant coefficient model.
(i) Average number of correct, wrong or missing-selection
Sample size Category Correct-selection Wrong-selection Missing-selection
n= 200
Y = 2 10.35 2.12 1.63
Y = 3 7.95 1.82 1.05
n= 300
Y = 2 11.77 1.12 0.23
Y = 3 8.80 1.06 0.20
n= 400
Y = 2 11.90 0.95 0.10
Y = 3 8.86 0.91 0.14
(ii) Average proportion of correct prediction within each category
Sample size Model Y = 1 Y = 2 Y = 3
n= 200
Our method 0.68 0.62 0.56
SCAD constant coefficient model 0.55 0.53 0.50
Full constant coefficient model 0.31 0.30 0.27
Oracle model 0.79 0.74 0.67
n= 300
Our method 0.74 0.69 0.60
SCAD constant coefficient model 0.55 0.53 0.50
Full constant coefficient model 0.38 0.36 0.32
Oracle model 0.79 0.74 0.67
n= 400
Our method 0.78 0.75 0.71
SCAD constant coefficient model 0.63 0.60 0.59
Full constant coefficient model 0.44 0.41 0.38
Oracle model 0.79 0.74 0.67
(iii) Average proportion of subjects being classified into a correct category
Sample size Model 90%−100% 80%−90% 70%−80%
n= 200
Our method 0.88 0.76 0.65
SCAD constant coefficient model 0.74 0.62 0.51
Full constant coefficient model 0.69 0.54 0.41
Oracle model 0.94 0.83 0.73
n= 300
Our method 0.92 0.80 0.69
SCAD constant coefficient model 0.77 0.68 0.56
Full constant coefficient model 0.72 0.58 0.45
Oracle model 0.94 0.83 0.73
n= 400
Our method 0.93 0.82 0.70
SCAD constant coefficient model 0.78 0.70 0.59
Full constant coefficient model 0.74 0.60 0.49
Oracle model 0.94 0.83 0.73
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